• FDA Approves First Gene Therapy for Hemophilia B

    9 days ago - By Medscape

    Etranacogene dezaparvovec is the first gene therapy option for adults with hemophilia B who currently use factor IX prophylaxis therapy and have repeated, spontaneous bleeding episodes.
    MDedge News
    Read more ...